|Tested species reactivity||Human, Non-human primate, Pig, Rabbit, Rat|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG1, kappa|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:800|
|Western Blot (WB)||1-2 µg/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-13093 targets Chromogranin A in IHC (P), ICC/IF and WB applications and shows reactivity with Human, Non-human primate, Porcine, Rabbit, and Rat samples.
The MA5-13093 immunogen is human pheochromocytoma.
Chromogranin A (a protein of 439-amino acids which is encoded on chromosome 14) is present in neuroendocrine cells throughout the body, including the neuroendocrine cells of the large and small intestine, adrenal medulla and pancreatic islets. It is an excellent marker for carcinoid tumors, pheo-chromocytomas, paragangliomas, and other neuro-endocrine tumors. Coexpression of chromogranin A and neuron specific enolase (NSE) is common in neuroendocrine neoplasms.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study.
MA5-13093 was used in immunohistochemistry to study the performance of the XELBEVOCT therapeutic regimen in patients with well-to-moderately differentiated neuroendocrine tumors
|Berruti A,Fazio N,Ferrero A,Brizzi MP,Volante M,Nobili E,Tozzi L,Bodei L,Torta M,D'Avolio A,Priola AM,Birocco N,Amoroso V,Biasco G,Papotti M,Dogliotti L||BMC cancer (14:null)||2014|
Human papillomavirus-associated adenocarcinoma of the base of the tongue.
MA5-13093 was used in immunohistochemistry to report on two cases of adenocarcinoma of the base of the tongue associated with HPV infection
|Hanna J,Reimann JD,Haddad RI,Krane JF||Human pathology (44:1516)||2013|
Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases.
MA5-13093 was used in immunohistochemistry to study the association of tumor staging with clinical outcome in neuroendocrine tumors of the appendix
|Volante M,Daniele L,Asioli S,Cassoni P,Comino A,Coverlizza S,De Giuli P,Fava C,Manini C,Berruti A,Papotti M||The American journal of surgical pathology (37:606)||2013|
Gastric histopathological findings and ghrelin expression in morbid obesity.
MA5-13093 was used in immunohistochemistry to study the histopathology of ghrelin-expressing cells in the stomach of morbidly obese patients
|Gündo¿an M,Çalli Dem¿rkan N,Tek¿n K,Aybek H||Turk patoloji dergisi (29:19)||2013|
Airway basal cell vascular endothelial growth factor-mediated cross-talk regulates endothelial cell-dependent growth support of human airway basal cells.
MA5-13093 was used in immunohistochemistry to study the expression VEGF isoforms by airway basal cells and the mechanism by which they regulate endothelial activation
|Curradi G,Walters MS,Ding BS,Rafii S,Hackett NR,Crystal RG||Cellular and molecular life sciences : CMLS (69:2217)||2012|
Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma.
MA5-13093 was used in immunohistochemistry to study the expression of the hASH-1 transcription factor in neuroendocrine breast carcinoma
|Righi L,Rapa I,Votta A,Papotti M,Sapino A||Virchows Archiv : an international journal of pathology (460:415)||2012|
HPV-associated neuroendocrine carcinoma of the oropharynx: a rare new entity with potentially aggressive clinical behavior.
MA5-13093 was used in immunohistochemistry to report on 8 cases of HPV- and tobacco-associated neuroendocrine carcinoma of the oropharynx
|Kraft S,Faquin WC,Krane JF||The American journal of surgical pathology (36:321)||2012|
Extraventricular neurocytomas: a morphological and histogenetic consideration. A study of six cases.
MA5-13093 was used in immunohistochemistry to study the morphological and histological features of neurocytomas in extraventricular locations
|Agarwal S,Sharma MC,Sarkar C,Suri V,Jain A,Sharma MS,Ailawadhi P,Garg A,Mallick S||Pathology (43:327)||2011|
Detection of bone marrow metastases of neuroblastoma with immunohistochemical staining of CD56, chromogranin A, and synaptophysin.
MA5-13093 was used in immunohistochemistry to detect the bone marrow metastases of neuroblastoma by immunohistochemical staining of specific proteins
|Park SJ,Park CJ,Kim S,Jang S,Chi HS,Kim MJ,Im HJ,Seo JJ||Applied immunohistochemistry and molecular morphology : AIMM (18:348)||2010|
Extra-adrenal composite paraganglioma with ganglioneuroma component presenting as a pancreatic mass.
MA5-13093 was used in immunohistochemistry to report on a case of extra-adrenal composite paraganglioma with ganglioneuroma component
|Inzani F,Rindi G,Tamborrino E,Cobelli R,Bordi C||Endocrine pathology (20:191)||2009|
Pulmonary meningothelial-like nodules: new insights into a common but poorly understood entity.
MA5-13093 was used in immunohistochemistry to study pulmonary meningothelial-like nodules
|Mukhopadhyay S,El-Zammar OA,Katzenstein AL||The American journal of surgical pathology (33:487)||2009|
Primary neuroendocrine carcinoma of the breast: a case report.
MA5-13093 was used in immunohistochemistry to report on a case of primary neuroendocrine carcinoma of the breast
|Yaren A,Kelten C,Akbulut M,Teke Z,Duzcan E,Erdem E||Tumori (93:496)||2007|
Basaloid adenocarcinoma. A new variant of pulmonary adenocarcinoma.
MA5-13093 was used in immunohistochemistry to report a clinical case of basaloid adenocarcinoma
|Marci V,Volante M,Cappia S,Righi L,Novello C,Scagliotti GV,Brambilla E,Papotti M||Virchows Archiv : an international journal of pathology (451:729)||2007|
Laparoscopic resection of urinary bladder paraganglioma: a case report.
MA5-13093 was used in immunohistochemistry to report on a case of aparoscopic resection of urinary bladder paraganglioma
|Dilbaz B,Bayoglu Y,Oral S,Cavusoglu D,Uluoglu O,Dilbaz S||Surgical laparoscopy, endoscopy and percutaneous techniques (16:58)||2006|
Pulmonary large cell carcinoma with rhabdoid phenotype.
MA5-13093 was used in immunohistochemistry The report on a patient with pulmonary large cell carcinoma with rhabdoid phenotype
|Yilmazbayhan D,Ates LE,Dilege S,Gulluoglu M,Tanju S,Kalayci G||Annals of diagnostic pathology (9:223)||2005|
MA5-13093 was used in immunohistochemistry to report on a case of anaplastic ependymoma.
|Erdo¿an G,Ozel E,Pe¿tereli HE,Salar Z,Tirak B,Karaveli S||APMIS : acta pathologica, microbiologica, et immunologica Scandinavica (113:301)||2005|
CDX-2 homeobox gene product expression in neuroendocrine tumors: its role as a marker of intestinal neuroendocrine tumors.
MA5-13093 was used in immunohistochemistry to study the expression of the CDX-2 homeobox gene product in neuroendocrine tumors
|Barbareschi M,Roldo C,Zamboni G,Capelli P,Cavazza A,Macri E,Cangi MG,Chilosi M,Doglioni C||The American journal of surgical pathology (28:1169)||2004|
Altered distribution of metaplastic Paneth, gastrin and pancreatic acinar cells in atrophic gastritic mucosa with endocrine cell lesions.
MA5-13093 was used in immunohistochemistry to study the altered distribution of metaplastic cell types in atrophic gastritic mucosa with endocrine cell lesions
|Deveci MS,Deveci G||The Tohoku journal of experimental medicine (202:13)||2004|
Concurrent lymph node metastases of medullary and papillary thyroid carcinoma in a case with RET oncogene germline mutation.
MA5-13093 was used in immunohistochemistry to report on a case of pituitary cancer with lymph node metastasis in a patient with a RET ongogene germline mutation
|Papi G,Corrado S,Pomponi MG,Carapezzi C,Cesinaro A,LiVolsi VA||Endocrine pathology (14:269)||2003|
Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
MA5-13093 was used in immunohistochemistry to study whether refining the grading of low-grade neuroendocrine tumors of the midgut and unknown origin is of prognostic/predictive value
|Van Eeden S,Quaedvlieg PF,Taal BG,Offerhaus GJ,Lamers CB,Van Velthuysen ML||Human pathology (33:1126)||2002|
EGF promotes neuroendocrine-like differentiation of prostate cancer cells in the presence of LY294002 through increased ErbB2 expression independent of the phosphatidylinositol 3-kinase-AKT pathway.
MA5-13093 was used in immunocytochemistry and immunohistochemistry to study the mechanism by which EGF promotes neuroendocrine-like differention of prostate cancer cells in the presence of a PI3 kinase inhibitor
|Cortés MA,Cariaga-Martinez AE,Lobo MV,Martín Orozco RM,Motiño O,Rodríguez-Ubreva FJ,Angulo J,López-Ruiz P,Colás B||Carcinogenesis (33:1169)||2012|
Chromogranin peptides in amyotrophic lateral sclerosis.
MA5-13093 was used in western blot to investigate the role of chromogranin peptides in amyotrophic lateral sclerosis
|Schrott-Fischer A,Bitsche M,Humpel C,Walcher C,Maier H,Jellinger K,Rabl W,Glueckert R,Marksteiner J||Regulatory peptides (152:13)||2009|
Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer.
MA5-13093 was used in western blot to investigate the role of two functional epitopes of pigment epithelial-derived factor in prostate cancer
|Filleur S,Volz K,Nelius T,Mirochnik Y,Huang H,Zaichuk TA,Aymerich MS,Becerra SP,Yap R,Veliceasa D,Shroff EH,Volpert OV||Cancer research (65:5144)||2005|
Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function.
MA5-13093 was used in western blot to investigate the influence of heparin-binding epidermal growth factor-like growth factor on prostate tumor growth
|Adam RM,Kim J,Lin J,Orsola A,Zhuang L,Rice DC,Freeman MR||Endocrinology (143:4599)||2002|